Literature DB >> 891529

Nitrosoalkanes as Fe(II) ligands in the 455-nm-absorbing cytochrome P-450 complexes formed from nitroalkanes in reducing conditions.

D Mansuy, P Gans, J C Chottard, J F Bartoli.   

Abstract

Primary and secondary aliphatic nitroalkanes RR'CHNO2, react with microsomal cytochrome p-450 in the presence of dithionite leading to new complexes with a Soret peak at 455 nm. The formation of these complexes is inhibited completely by CO and partially by metyrapone. However, once formed, their exogenous ligand is not displaced by excess CO. By deoxycholate treatment they are transformed into 423-nm-absorbing cytochrome P-420 complexes, which are spectrally similar to the corresponding RR'CHNO2-derived myoglobin complexes. The 455-nm-absorbing complexes are equally produced from RR'CHNO2 reduction, microsomal NADPH-dependent oxidation of the corresponding hydroxylamine RR'CHNHOH, or interaction of the nitrosodimer (RR'CHNO)2 with reduced cytochrome P-450. All the reported results are consistent with the involvement of a new class of ligands of cytochrome P-450-Fe(II), which are the unstable aliphatic nitrosomonomers RR'CHNO, whose nitroso group is isoelectronic with dioxygen and whose stabilisation results from their strong binding to heme-Fe(II), thus explaining the observed inhibition of the hydroxylating function of cytochrome P-450.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891529     DOI: 10.1111/j.1432-1033.1977.tb11631.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Metabolic intermediate complex formation of human cytochrome P450 3A4 by lapatinib.

Authors:  Hideo Takakusa; Michelle D Wahlin; Chunsheng Zhao; Kelsey L Hanson; Lee Sun New; Eric Chun Yong Chan; Sidney D Nelson
Journal:  Drug Metab Dispos       Date:  2011-03-01       Impact factor: 3.922

2.  The nitrosoamphetamine metabolite is accommodated in the active site of human hemoglobin: Spectroscopy and crystal structure.

Authors:  Samantha M Powell; Leonard M Thomas; George B Richter-Addo
Journal:  J Inorg Biochem       Date:  2020-09-29       Impact factor: 4.155

3.  1H NMR structure of the heme pocket of HNO-myoglobin.

Authors:  Filip Sulc; Everly Fleischer; Patrick J Farmer; Dejian Ma; Gerd N La Mar
Journal:  J Biol Inorg Chem       Date:  2002-12-14       Impact factor: 3.358

4.  Interaction of ligands with cytochrome P-450. On the 442 nm spectral species generated during the oxidative metabolism of pyridine.

Authors:  P Hlavica; J Mietaschk; I Baden
Journal:  Biochem J       Date:  1982-05-15       Impact factor: 3.857

Review 5.  The role of metabolites in predicting drug-drug interactions: focus on irreversible cytochrome P450 inhibition.

Authors:  Brooke M VandenBrink; Nina Isoherranen
Journal:  Curr Opin Drug Discov Devel       Date:  2010-01

Review 6.  Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.

Authors:  Jaydeep Yadav; Erickson Paragas; Ken Korzekwa; Swati Nagar
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

7.  Stereoselective inhibition of CYP2C19 and CYP3A4 by fluoxetine and its metabolite: implications for risk assessment of multiple time-dependent inhibitor systems.

Authors:  Justin D Lutz; Brooke M VandenBrink; Katipudi N Babu; Wendel L Nelson; Kent L Kunze; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2013-06-19       Impact factor: 3.922

8.  Insight into the preferential N-binding versus O-binding of nitrosoarenes to ferrous and ferric heme centers.

Authors:  Erwin G Abucayon; Jia-Min Chu; Megan Ayala; Rahul L Khade; Yong Zhang; George B Richter-Addo
Journal:  Dalton Trans       Date:  2021-03-16       Impact factor: 4.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.